Baoji Pharmaceutical

About:

Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.

Website: http://www.baopharma.com

Top Investors: Oriental Fortune Capital, Shanghai Biomedical Industrial Equity Investment Fund, Shanghai STVC Group, Center Ventures, Haitong Innovation Capital Management

Description:

Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."

Total Funding Amount:

$100M

Headquarters Location:

Baoshan, Shanghai, China

Founded Date:

2019-01-01

Contact Email:

BJHR(AT)baopharma.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-07-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai